Catalyst Wire Dossier Catalyst Wire Dossier

Thymosin beta-4

thymosin beta-4 · Beijing Northland Biotech Co., Ltd.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Thymosin beta-4, covering 2010-02-01 to 2024-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction [Phase 2]

See pricing